To amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.

10/12/2024, 8:05 AM
Referred to the House Committee on Energy and Commerce.
Congress
118

Number
HR - 9979

Introduced on
2024-10-11

# Amendments
0

Sponsors
+5

Cosponsors
+5

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Referred to the House Committee on Energy and Commerce.
Alternative Names
Official Title as IntroducedTo amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.

Comments

Recent Activity

Latest Action10/11/2024
Referred to the House Committee on Energy and Commerce.